sensors back to basics · 2018-07-19 · disclosure richard a. bonato, ph.d., m.a., rpsgt ceo and...

140
DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON ® Medical Corporation Has been involved in the study of sleep and its disorders since 1986, has taught courses on Sleeping & Dreaming at Carleton University, was the director of a sleep disorders laboratory, and has been an author, co-author, reviewer, and examiner in various educational organizations within the sleep field, including the AASM, AAST, BRPT, and has served on the Executive of the Canadian Sleep Society. BRAEBON manufactures and sells wearable sleep sensors, home apnea recorders, and a micro-recorder, DentiTrac, for tracking oral appliance compliance.

Upload: others

Post on 25-Jul-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

DISCLOSURE

Richard A. Bonato, Ph.D., M.A., RPSGT

CEO and Co-Founder of BRAEBON® Medical Corporation

Has been involved in the study of sleep and its disorders since

1986, has taught courses on Sleeping & Dreaming at Carleton

University, was the director of a sleep disorders laboratory, and

has been an author, co-author, reviewer, and examiner in

various educational organizations within the sleep field,

including the AASM, AAST, BRPT, and has served on the

Executive of the Canadian Sleep Society.

BRAEBON manufactures and sells wearable sleep sensors,

home apnea recorders, and a micro-recorder, DentiTrac, for

tracking oral appliance compliance.

Page 2: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Oral Appliance Therapy for OSA

and Measuring Compliance in

Custom Oral Devices for OSA

Page 3: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Objectives

• How does OAT (and CPAP) work and how do

you know it is working?

• Compliance and why measure it?

• Test Treat Trac®

• Technology: understanding what to use

• Types of patients who may benefit from oral

appliance compliance measurement

• Evaluation of oral appliance success:

compliance reporting

Page 4: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

iOS & Droid App – Free Dental Sleep Study Guide

Page 5: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Page 6: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Sleep Disordered Breathing Spectrum

Page 7: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep
Page 8: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Two key questions for DSM:

1. How does OAT work, how do you

know oral appliance therapy (OAT) is

working for an apnea patient?

2. How do you know if a patient is

wearing their oral appliance?

Page 9: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

®

Page 10: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Change….

• Omnipresent

• Very difficult for many people

• Technology change (Test. Treat. Trac.)

• What was life like in the year 1900?

• What was the environmental crisis of

the day?

Page 11: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Technology we use…..

Lab (PSG) vs home (HSAT)

Type 1 PSG Type 2 HST Type 3 HSAT Type 4 HSAT

Sleep Tech in

Sleep Lab

No Tech, Home

(MediPalm/Byte)

No Tech

Home (MediByte)

No Tech,

Home (Oximeter)

16 or more

channels: EEG,

EOG, EMG, EKG,

Legs

7 or more: EEG,

EOG, EMG

4 or more 1 or 2

Thermal airflow,

Pressure airflow,

Ventilatory effort,

Snoring, Body Pos

Thermal airflow,

Pressure airflow,

Ventilatory effort,

Snoring, Body Pos

Thermal airflow,

Pressure airflow,

Ventilatory effort,

Snoring, Body Pos

Perhaps pressure

airflow

SpO2 SpO2 SpO2 SpO2

Page 12: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

SCOPER Scale: Collop et al. 2011

Page 13: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Polysomnogram = PSG (full PSG or full poly)

1989: >200 lbs; 6’ high

Page 14: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Full Polysomnograpy (Type 1)

2003: ½ lb; 4.75” x 2.75” x 0.75” (L x W x H)

Page 15: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Polysomnogram = multiple sleep graph recording

EEG EOG

Chin EMG

Legs EMG

SpO2

Chest effort

Abdominal effort

EKG

Body Position

Airflow

Page 16: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Type 1

Page 17: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

With in-lab PSG (Type 1)….

• We can evaluate virtually all sleep

disorders (about 90)

• Plus MSLT & MWT

• But PSG is NOT a gold standard for OSA

• There is no anatomical or biological

gold standard for OSA

• Best at the time and we got stuck with it

Page 18: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Home sleep apnea testing (HSAT): Type 2 / 3

2006: 93 grams; 2.75” x 2” x 0.70”

Page 19: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Type 2 Home Sleep Recording

Page 20: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Type 2: EEG, EOG, EMG + cardiopulmonary

Page 21: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Unambiguous Stage REM sleep….

Page 22: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep
Page 23: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Type 1 or Type 2

Page 24: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

EEG During sleep stages

Beta = 16 to 30 Hz EEG

Gamma = > 30 Hz EEG

CNV & DC Potentials

Alpha EEG = 8 to 12 Hz

Theta EEG = 4 to 8 Hz

Delta EEG = 0.5 to 4 Hz

Sleep Spindle = 12 to 14 Hz

NREM REM Sleep Cycle

Copyright 2011 Braebon

Page 25: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

OSA SNORING EKG BRUXISM

Different tests are easily configured:

bruxism, EKG, snoring, PLMs (legs), etc.

Copyright 2011 Braebon

Page 26: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

ORAL CPAP PAP INDUCED

APPLIANCE AUTOPAP PLMS

Different therapies can be monitored.

Copyright 2011 Braebon

Page 27: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Simultaneously record:

1. EEG

2. EOG

3. EMG

4. EKG

5. Snore

6. Pressure Airflow

7. Flow Limitation

8. Thermal Airflow

9. Chest Effort

10. Abdominal Effort

11. Sum

12. SpO2

13. Pulse Rate

14. Body Position

15. *PPG (Photoplethysmogram)

16. User Events

Page 28: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

HSAT Type 3 simpler cardiopulmonary recorder

2008: 91 grams; 2.75” x 2” x 0.70”

Page 29: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

BRAEB

ON

Type 3 but with fewer channels

Copyright 2011 Braebon

Page 30: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Simultaneously record:

1. Snore

2. Pressure Airflow

3. Flow Limitation

4. Chest Effort

5. SpO2

6. Pulse Rate

7. Body Position

8. *PPG (Photoplethysmogram)

9. User Events

Page 31: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Type 4: overnight pulse oximetry

Page 32: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Type 4: Pulse Oximetry (+ more?)

Page 33: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Simultaneously record:

1. Snore

2. Pressure Airflow

3. Flow Limitation

4. SpO2

5. Pulse Rate

6. *PPG (Photoplethysmogram)

Page 34: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

DentiTrac micro-recorder

2015: 5 grams; ~12 x 11 x 5 mm

Page 35: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

What do these devices have in common?

• They are ALL recorders

Page 36: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

What do we do with this info?

• SDB: AHI is often focus

• Why?

• Other measures: Arousals, RDI, flow

limitation, RERAs, PRV, etc.

• Goal is successful treatment: CPAP or

OAT

Page 37: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

How does CPAP work?

• A CPAP machine blows room air into

your airway so it doesn't collapse when

you breathe in.

• Interface covers nose (maybe mouth,

but nose better)

• Think of CPAP as an air splint

• Effective but usually low compliance

Page 38: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2013 Braebon

Page 39: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

CPAP (cont’d)

• Bedside blower size is usually not an

issue for people

• Blowers are getting smaller for easier

travel: Travel PAP

• Mask interfaces remain the largest

issue for most people

Page 40: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

How does OAT work?

• A device is placed in the mouth and

holds the mandible and / or tongue

forward, usually with increased vertical

opening, which acts as a mechanical

splint to increase airway space so your

airway doesn’t collapse (as much) when

you breathe in

• TRD vs MRD

Page 41: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep
Page 42: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

How does OAT work?

• Custom usually better than boil & bite

• Titratable usually better than non

• Bite registration?

• Phonetic

• George Gauge

Page 43: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

86% increase

in anterior-

posterior

area

Page 44: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

How does OAT compare to CPAP?

Chan & Cistulli, 2009

Page 45: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Are you better off using something

that works well (i.e., CPAP with AHI &

PSG measures) but using it less OR

are you better off using something

that does not work quite as well (i.e.,

OAT) but using it more?

Page 46: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Amer J Resp Crit Care Med 2013

Page 47: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

• Measured cardiovascular (24-h blood

pressure, arterial stiffness), subjective

sleepiness, driving simulator

performance, and quality of life

(Functional Outcomes of Sleep

Questionnaire-36)

• Randomly assigned 126 (108

completed) patients with moderate to

severe OSA

Page 48: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

What This Study Adds to the Field

In the short term, health outcomes in patients with moderate

to severe OSA were similar after treatment with

CPAP and MAD. This was likely explained by the greater

efficacy of CPAP being offset by inferior compliance relative

to MAD. These findings strongly challenge current

practice parameters recommending MAD treatment be

considered only in patients with mild to moderate OSA.

Long-term comparative effectiveness studies between

CPAP and MAD that include objectively measured treatment

compliance are needed to better define treatment

strategies for patients with OSA.

CPAP reduced AHI better, but moderate to

severe OSA patients were similar after

treatment with CPAP and oral appliance.

Because patients wear oral appliances

more than they wear CPAP.

Long-term studies needed to compare

CPAP and MAD using objective

compliance measurement [e.g., DentiTrac].

Page 49: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

• Why did Philips et al (2013) find this?

• “Mean Disease Alleviation” (later)

Page 50: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Page 51: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

• Q/ How do you know if CPAP Tx is

working for the patient?

Page 52: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Pt with Hx of MI, TIA….

Page 53: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Page 54: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Page 55: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Page 56: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Page 57: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

• Q/ How do you know if OA Tx is

working for the patient?

Page 58: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Page 59: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Page 60: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Before: AHI 9.5 After: AHI 11.2

Page 61: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Before: AHI 9.5

After: AHI 11.2 Patient feels better now

Page 62: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Pulse Rate Variability from 60 to 120

Overall AHI / RDI = 15.7 / 24.2

Page 63: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

But supine this person falls into mild….

Page 64: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Follow-up: Baseline vs OAT Tx

16.3

3.8

Page 65: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

CPAP Noncompliant patient using temp appliance (in a tent)

38

11

Page 66: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

72

6

Copyright 2012 Braebon

Page 67: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Page 68: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

• We’ve talked about technology, we’ve

talked about how CPAP & OAT work,

how to measure their success

• How do you actually know if people

are actually complying or adhering to

treatment?

Page 69: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

What is compliance?

• “Extent to which a person’s behavior (taking

meds, following a diet) coincides with medical

or health advice” (Haynes et al., 1979)

• Also, adherence, concordance or cooperation

(not passive terms, suggest more choice, etc.)

• For dental sleep medicine or orthodontics:

extent to which the person is using prescribed

therapy

Copyright 2017 Braebon

Page 70: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Direct or Indirect compliance measurement

• Direct:

• Use physiological measures (airflow, body temp)

• Less subject to bias

• This is where CPAP has been

• Indirect:

• Self-reports are more frequently used and easier

• More subject to bias

• This is where OAT has been

Copyright 2017 BRAEBON

Page 71: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Why is it important to measure?

• Better compliance = better results: reduced

treatment time (ortho)

• Noncompliance = waste of resources =

insurance payers will no longer pay (CPAP)

Copyright 2017 BRAEBON

Page 72: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Achilles heel of CPAP = compliance

CPAP Achilles heel: compliance

• mask is a huge issue

• not size of blower

• not humidity

• not hose

Copyright 2017 BRAEBON

Page 73: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Two Achilles heels of OAT

1. Objective compliance

measurement

2. A priori determination of

successful OAT candidate

Page 74: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Definition of compliance: CPAP

• To qualify to retain funding for CPAP after an

initial 3-month trial, a patient must

demonstrate “continued use of CPAP therapy”:

• > 4 hrs per night for > 70% of all nights

during a 30-day period of the initial 90-day

trial

• Historical def’n is >4 hrs nightly five

nights per week

Copyright 2017 BRAEBON

Page 75: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Europe

Qualifying for continued CPAP funding

• France: > 3 hrs per night 7 days per week

• Germany: > 4 hrs per night

• Italy: > 3 hours per night

• Spain: > 5 hours per night

Which definition is more correct?

Copyright 2017 BRAEBON

Page 76: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

CPAP machines & the luxury of size

Copyright 2017 BRAEBON

Page 77: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

A CPAP report…..

Copyright 2017 BRAEBON

Page 78: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

AHI, Pressure (cm H20), leak, hours of use

Copyright 2017 BRAEBON

Page 79: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Let me tell you about our patient Juan…

• Juan is from Columbia

• Juan is a bit of a round individual

• Juan has a BMI of 32.5

Copyright 2017 BRAEBON

• Mallampati score of 0 (or less)

• Weight = 1.36kg and Height = 8”

Page 80: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Meet Juan….

Copyright 2017 BRAEBON

Page 81: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Juan needs CPAP @ 11 cmH20

Copyright 2017 BRAEBON

Page 82: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Page 83: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Page 84: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Gaming CPAP compliance

• Quick & dirty demonstration of CPAP

compliance deception:

• Cannot guarantee that it is actually

that patient wearing that particular

CPAP

• Could be bedpartner or a simple or

more sophisticated simulation

• This has important implications for the

future

Page 85: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

CPAP Compliance / Intolerance

• When adherence is defined as greater than 4

hours of nightly use, 46 to 83% of patients with

obstructive sleep apnea have been reported to

be nonadherent to treatment.

Weaver & Grunstein (2008). Proc Am Thorac Soc Vol 5. pp

173–178, 2008

• CPAP Intolerance is a large target market for

dentists

Copyright 2017 BRAEBON

Page 86: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

CPAP is state of the art treatment but…

After about a year 50% of people

stop using it

Copyright 2017 BRAEBON

Page 87: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Kribbs, Pack, Kline, Getsy, Schuett, Henry,

Maislin, Dinges. Effects of one night without

nasal CPAP treatment on sleep and sleepiness

in patients with obstructive sleep apnea.

Am Rev Respir Dis 1993;147:1162–1168.

Sleeping without CPAP for one night

reversed virtually all of the sleep and

daytime alertness gains derived from

sleeping with CPAP.

Page 88: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Page 89: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

AASM OA Practice Parameters: 2005

• Adherence data for OAs mostly relies on

subjective reports.

• In contrast, CPAP compliance is

routinely monitored objectively.

• Development of similar capabilities for

OA therapy should be pursued for both

research and clinical purposes.

What about OAT compliance measurement?

Copyright 2017 BRAEBON

Page 90: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Two Achilles heels of OAT

1. Objective compliance

measurement

Page 91: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

What is OAT compliance?

1. How compliant are you everyday?

2. How compliant are you on days you are

wearing it for at least 15 min?

3. How compliant are you > 4 hrs daily for 5

out of 7 days for the entire data collection

period? (historical CPAP def’n)

4. How compliant are you > 4 hrs daily during

a 30-day period of the initial 90-day usage?

(this is the new CPAP def’n)

Copyright 2017 BRAEBON

Page 92: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

4. How compliant are you if you changed

appliances and now have a new one

(i.e., more than one)?

5. How compliant are you since the last

time we looked (uploaded) at the data?

What is OAT compliance? (cont’d)

Page 93: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

• Headgear timer: miniature electronic watch with memory

• Pts increased wearing time when told about monitoring.

• Hours increased from 35-50 / week to 100 / week.

Page 94: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Northcutt, M. E. The timing headgear. J. Clin. Orthod.

V.8, p.321-324, Jun. 1974.

• Timing headgear neckband and timer

• Timing headgear readout monitor

• Neckband placed on monitor for readout

Page 95: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Orthokinetics: Compliance Science System

• Objectively inform orthodontists and patients the

number of hours the headgear is being worn

Page 96: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

• Compliance Science System in 46 patients (blind)

• After two months two groups set up:

• uncooperative <16 hrs daily now informed of monitor

• cooperative > 16 hrs daily remain blind to monitor

• 4 months later: statistically significant increase in

usage in the uncooperative group

Page 97: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Creative children found a way around it….

Page 98: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Temperature sensor with periodic sampling

Page 99: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

What is an OAT compliance

monitor (DentiTrac)?

Is it a sensor? NO

Is it a chip? NO

Is it a micro-recorder? YES

Page 100: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Both are dataloggers (recorders)

Page 101: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Having a lab embed a recorder into an appliance

is as simple as inserting a label…

•We anticipate most dentists will

check a box when ordering the

appliance

Page 102: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Page 103: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Page 104: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Page 105: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Page 106: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Page 107: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Page 108: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Page 109: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Page 110: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Page 111: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Auxilary can do much of this:

• Data is read by the base station and

uploaded to the cloud portal for analysis

and reporting

• Reading data is as simple as placing the

OA into the base station

Page 112: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Page 113: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Page 114: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Page 115: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

DentiTrac processed data

2. CWhenWorn = 91%

1. Ceveryday = 87%

3. C5 of 7 = 95%

4. C90 = 100%

Page 116: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

CPAP compliance &

OAT compliance data

Page 117: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Page 118: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Page 119: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

CPAP & OAT Compliance Data Detailed View

Pearson r = 0.92, r2 = .85; t-test = NS

Page 120: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Definition of compliance: OAT

Copyright 2017 BRAEBON

Page 121: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Vanderveken et al. 2013: Thorax

• Objective compliance measurement &

OAT

• Compared objective and subjective OAT

compliance

• Introduced “mean disease alleviation”

Page 122: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Vanderveken et al. 2013

• Objective OAT compliance measurement

allows calculation of mean disease

alleviation, defined as a combined function of

efficacy and compliance, being a measure of

overall therapeutic effectiveness

• Effectiveness = compliance x efficacy.

Page 123: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

• OA efficacy (%) = baseline AHI minus

AHI with OA (e.g., 10 – 4.4 = 56%)

• Mean Disease Alleviation = product of

adjusted compliance (worn 91.2% of the

time) with therapeutic OA efficacy (56%

above = 51.1%

Vanderveken et al. 2013

Page 124: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Mean disease alleviation

Page 125: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

CPAP example…

• If the AHI on CPAP drops from 50 to 2

then it is a 96% reduction

• If the patient only wears the CPAP 50%

of the time then Mean Disease

Alleviation = 50% x 96% = 48%

Page 126: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

• Higher compliance with OAT = similar

adjusted effectiveness as compared

with CPAP

• OAT is not as good as CPAP in

reducing AHI, but MDA values might be

comparable with CPAP because of the

higher compliance with OA therapy (and

that’s what Philips et al. 2013 said too)

Vanderveken et al. 2013

Page 127: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

More research using objective OA compliance…

51 patients with mild to moderate OSA

Page 128: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Dieltjens et al. 2015 JAMA Oto Head & Neck

• Neither anthropometric & polysomnographic

parameters nor reports of excessive daytime

sleepiness correlated with OAT compliance

• Two parameters which correlated with higher

OAT objective compliance were decreased

snoring and dry mouth

Page 129: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Journal Dental Sleep Medicine: 2015

CPAP & OAT have limitations: CPAP Tx often

has low patient acceptance, poor tolerance and

suboptimal compliance; OAT usually has inferior

PSG efficacy when compared to CPAP

Page 130: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

According to MDA concept….

• OSA Tx with CPAP, OAT or other non-

CPAP modalities, as a single treatment,

usually means incomplete elimination of

the disorder with average MDA index,

as a marker of real clinical

effectiveness, ranging from 40 to 59%

Page 131: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Vanderveken 2015….

• Greater CPAP efficacy is offset by its

inferior compliance relative to OAT

• This is not imaginary, and results in a

similar overall effectiveness for both

therapeutic modalities

Page 132: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

• Mandibular advancement + tongue

protrusion = effective treatment for

moderate-to-severe OSA: tongue bulb

added to MRD provides further

therapeutic effectiveness.

Vanderveken 2015: Combo Tx

Dort & Remmers

JCSM 2012

Page 133: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

• OAT + multilevel upper airway surgery

• OAT + positional Tx

• Recent study reported MDA increased

from 42% to 70% when OAT was

combined with positional Tx

(Dieltjens et al., 2014)

Vanderveken 2015: Combo Tx

Page 134: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

But can we game OAT same as CPAP?

• It is much more difficult to deceive OAT

with DentiTrac objective compliance

than to deceive CPAP with Juan

• My OA won’t fit my bedpartner

• My dog luvs my OA as a chew toy

• Juan is not a substitute

• What about a heated water bath?

Page 135: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

Page 136: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

• Bϋchi heating bath deception

• 2 litres of water warmed to 35 C (95 F)

between 2100 and 0700 to simulate wearing

• Off 0700 to 1400

• On again 1400 to 1600 and 1700 to 1900

• Off 1900 to 2100

• Thus, total of 14 hrs wearing & 10 non-

wearing every 24 hours

Schott & Goz, Journal of Orofacial

Orthopedics, 2010, 79, pp 339-347.

Page 137: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2017 BRAEBON

With a simple temp measurement device,

they concluded that the warm water

bath could deceive the temperature

sensing technology and report wearing

when not actually worn

The DentiTrac was not susceptible to

this deception because more than

temperature is being recorded and

anti-deception algorithms are

implemented

Page 138: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

To conclude:

• Exciting times for OA Tx

• OAT compliance measurement is a

rapidly expanding frontier of dental

sleep medicine

• New standards evolving

• Modeled after the existing CPAP

compliance paradigm

• Test. Treat. Trac.®

Page 139: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Where to go from here?

• Principles & Practice of Sleep Medicine (6th Ed)

• ASBA Diplomate Exam

Page 140: Sensors back to Basics · 2018-07-19 · DISCLOSURE Richard A. Bonato, Ph.D., M.A., RPSGT CEO and Co-Founder of BRAEBON® Medical Corporation Has been involved in the study of sleep

Copyright 2010 Braebon

Thank you!

[email protected]